cas 40794-04-5|| where to buy 4-Chloro-2-methoxy-1-methylbenzene

製品名:4-Chloro-2-methoxy-1-methylbenzene

IUPAC Name:4-chloro-2-methoxy-1-methylbenzene

包装単位	有効在庫	価格（USD）
CM283380-5g	in stock	ȋȋ
CM283380-10g	in stock	Əŭƅ
CM283380-25g	in stock	ƏȤǺ
CM283380-100g	in stock	ȋƏœ

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 40794-04-5 regularly via the above email.

追記事項

Verification code*

refresh

: CAS番号:40794-04-5; 分子式:C8H9ClO; 融点:-; SMILESコード:CC1=CC=C(Cl)C=C1OC; 密度:

: カタログ番号:CM283380; 分子量:156.61; 沸点:204°C at 760 mmHg; MDL番号:MFCD07368289; 保管方法:Store at 2-8°C.

: Crinecerfont; The New England Journal of Medicine publishes the primary CAHtalyst™ Adult Phase 3 study results of Crinecerfont for the treatment of congenital adrenal hyperplasia (CAH). Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) is a rare genetic disorder, affected by a lack of cortisol and/or aldosterone. Corticotropin-releasing factor type 1 receptor (CRF1) antagonism is shown to clinically decrease ACTH production and adrenal androgen levels.
Neurocrine's Crinecerfont is an investigational, selective CRF1 antagonist being developed to reduce and control excess adrenocorticotropic hormone (ACTH) and adrenal androgens. The phase 3 study meets primary and important key secondary endpoints, including a significant reduction in androstenedione levels and lowering glucocorticoid dosing.